Cadence Capital Management LLC Takes $1.55 Million Position in Express Scripts Holding Company (ESRX)
Cadence Capital Management LLC bought a new position in Express Scripts Holding Company (NASDAQ:ESRX) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 24,472 shares of the company’s stock, valued at approximately $1,550,000.
Several other institutional investors have also bought and sold shares of ESRX. Burt Wealth Advisors increased its holdings in shares of Express Scripts by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the last quarter. CKW Financial Group grew its holdings in Express Scripts by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after purchasing an additional 300 shares during the last quarter. IHT Wealth Management LLC grew its holdings in Express Scripts by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after purchasing an additional 145 shares during the last quarter. First Personal Financial Services grew its holdings in Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after purchasing an additional 1,400 shares during the last quarter. Finally, FNY Partners Fund LP bought a new position in Express Scripts during the 1st quarter valued at about $138,000. Hedge funds and other institutional investors own 88.44% of the company’s stock.
In other Express Scripts news, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Over the last three months, insiders sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is owned by corporate insiders.
Several brokerages recently commented on ESRX. Jefferies Group reiterated a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Royal Bank Of Canada set a $66.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Wednesday, October 25th. Robert W. Baird upped their price target on shares of Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. Mizuho set a $67.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Tuesday, October 24th. Finally, Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Six equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $70.34.
Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at $64.41 on Friday. The stock has a market cap of $36,916.19, a PE ratio of 9.53, a price-to-earnings-growth ratio of 0.96 and a beta of 0.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.25.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.90. The company had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.74 EPS. equities research analysts anticipate that Express Scripts Holding Company will post 7.01 earnings per share for the current year.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.